Current Neuropharmacology

Bentham Science Publishers

Evaluation status available after sign-in

About the journal

Current Neuropharmacology is a journal published by Bentham Science Publishers in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Bentham Science Publishers
ISSN
1570-159X · 1875-6190
Country
Netherlands
Access
Not open access / not declared

Index listings

  • MEDLINE · 2015-01-01
  • PUBMED · 2004-01-01
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Actual review time (measured)
104 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

2301

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

138

i10-index

1316

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
53%
ORCID iDs in current deposits
29%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101157239
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Neuroscience and Neuropharmacology Research
  • Neuroscience and Neuropharmacology Research
  • Tryptophan and brain disorders
  • Tryptophan and brain disorders
  • Neurotransmitter Receptor Influence on Behavior
  • Neurotransmitter Receptor Influence on Behavior
  • Alzheimer's disease research and treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
Show all subjects (50)
  • Alzheimer's disease research and treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Cholinesterase and Neurodegenerative Diseases
  • Cholinesterase and Neurodegenerative Diseases
  • Stress Responses and Cortisol
  • Stress Responses and Cortisol
  • Treatment of Major Depression
  • Treatment of Major Depression
  • Parkinson's Disease Mechanisms and Treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Pain Mechanisms and Treatments
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Pain Mechanisms and Treatments
  • Schizophrenia research and treatment
  • Nicotinic Acetylcholine Receptors Study
  • Schizophrenia research and treatment
  • Nicotinic Acetylcholine Receptors Study
  • Epilepsy research and treatment
  • Epilepsy research and treatment
  • Cannabis and Cannabinoid Research
  • Receptor Mechanisms and Signaling
  • Cannabis and Cannabinoid Research
  • 14-3-3 protein interactions
  • Receptor Mechanisms and Signaling
  • 14-3-3 protein interactions
  • Mitochondrial Function and Pathology
  • Neurological disorders and treatments
  • Mitochondrial Function and Pathology
  • Neurogenesis and neuroplasticity mechanisms
  • Neurological disorders and treatments
  • Neurogenesis and neuroplasticity mechanisms
  • Cancer Mechanisms and Therapy
  • Cancer Mechanisms and Therapy
  • Neurological Disease Mechanisms and Treatments
  • Ion channel regulation and function
  • Bipolar Disorder and Treatment
  • Neurological Disease Mechanisms and Treatments
  • Bipolar Disorder and Treatment
  • Ion channel regulation and function
  • Genetic Neurodegenerative Diseases
  • Genetic Neurodegenerative Diseases

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: